The Department of Pharmaceutical Care & Health Systems (PCHS) advances the practice of pharmaceutical care and its role in the healthcare system for the benefit of patients & society through education, research, & service.
Social & Administrative Pharmacy Graduate Program
Study the social, psychosocial, political, legal, historic, and economic factors that impinge upon the use, non-use and abuse of drugs. Learn more about SAPh Degree Programs
Cultivating Pharmacy Practice
PCHS is dedicated to the advancement of pharmaceutical care. Pharmaceutical care was originally conceptualized by faculty within our department and continues to be an integral focus to our departmental identity. 
Our faculty engage in a diverse array of pharmacy practice models and services in partnership with healthcare systems, health disciplines, and the community at large to provide high-quality patient-centered care. Our faculty meet this need through patient care, practice-based research, practice innovation, and education. Learn more about our practice faculty
Driving Research and Scholarship
Faculty and trainees within our department study the pharmacy profession, patient care behaviors, government policies, and the economic, clinical, and humanistic aspects of medications. 
Learn more about our research and scholarship in:
- Patient Care
- Pharmaceuticals and Public Policy
- Educational Research
Advancing Education
PCHS embraces a leadership role in curricular innovation at the College. Our faculty are serving in leadership roles that are creating new learning experiences for Doctor of Pharmacy students and modeling innovative teaching and learning strategies in a variety of courses. Learn more about our advancing education in:
Curricular Domains- PharmD Emphasis - Leadership
- Advancement of Experiential Education
- Innovations in Teaching
Faculty Spotlight:
Dr. Jean Moon & Dr. Jody Lounsbery
Dr. Jean Moon and Dr. Jody Lounsbery are faculty in PCHS, College of Pharmacy at the Broadway Family Medicine Clinic. Dr. Moon is the Program Director for the Postgraduate Pharmacy Residency Program. Dr. Lounsbery is an Assistant Director for the Postgraduate Pharmacy Residency Program.
Research Spotlight:
Dr. Ann Philbrick, PharmD, FCCP, BCPS, BCACP
Dr. Ann Philbrick is an associate professor in PCHS, College of Pharmacy and the department of Family Medicine and Community Health at the University of Minnesota. She is on the faculty of Woodwinds Hospital Family Medicine Residency Program and maintains her pharmacy practice at Bethesda Family Medicine Clinic.
PCHS Announcements
Ann Philbrick, PharmD, FCCP, BCPS, BCACP, associate professor in the Department of Pharmaceutical Care & Health Systems, has been selected as an inductee into the Academy for Excellence in Clinical Practice.
Exploring the medication experience of African American women living with or at high risk for chronic kidney disease: A phenomenological investigation.
Dr. Brian Isetts joins partners in MidAtlantic, Midwest and Hawaii regions.
Pages
PCHS in the News
The Office of Discovery and Translation (ODAT) funded eight projects this fall to improve health equity and accessibility in Minneapolis and across Minnesota. Wendy St Peter, PharmD, is leading a project to reduce medical-related disparities in African Americans with chronic kidney disease through her national initiative "Advancing Kidney Health Through Optimal Medication Management."
Stephen Schondelmeyer, PharmD, PhD, was invited to testify at a Senate Hearing of the Homeland Security & Govt. Affairs Committee. COVID-19 Part II: Evaluating the Medical Supply Chain and Pandemic Response Gaps.
Jon Schommer, MS, PhD, RPh, was named ed Editor-in-Chief of Pharmacy. In 2018, he joined Pharmacy as an associate editor. In the past 3 years, Dr. Schommer has been active in editorial work and has done an excellent job. Taking on the new role, Dr. Schommer has a message for you and all Pharmacy readers, expressing his enthusiasm and expectation of the journal. Please see: https://www.mdpi.com/2226-4787/9/2/73.
Stephen Schondelmeyer, PharmD, PhD, is a key contributor to the COVID19--CIDRAP Viewpoint: Part 6 Ensuring a Resilient US Prescription Drug Supply.
Stephen Schondelmeyer, PharmD, PhD, is quoted in a Politico story about the drug industry pushing the FDA to solve its growing inspection backlog.